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Abstract
Genome-wide association studies (GWAS) have been successful in detecting variants corre-
lated with phenotypes of clinical interest. However, the power to detect these variants depends
on the number of individuals whose phenotypes are collected. Thus, for phenotypes that are
difficult to collect, the sample size may be insufficient to achieve the desired statistical power.
Often, while the phenotype of interest is difficult to collect, surrogate phenotypes or related
phenotypes are easier to collect and have already been collected in very large samples. In this
paper, we take advantage of these additional related phenotypes to impute the phenotype of
interest or target phenotype and then perform association analysis. Our approach leverages the
correlation structure between phenotypes to perform the imputation. The correlation structure
can be estimated from a smaller complete dataset for which both the target and related phe-
notypes have been collected. Under some assumptions the statistical power can be computed
analytically given the correlation structure of the phenotypes used in imputation. In addition,
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our method can impute the summary statistic of the target phenotype as a weighted linear
combination of the summary statistics of related phenotypes. Thus, our method is applicable
to datasets for which we only have access to summary statistics and not the raw genotypes.
We illustrate our approach by analyzing associated loci to triglycerides (TG), body mass index
(BMI), and systolic blood pressure (SBP) in the Northern Finland Birth Cohort dataset.
1 Introduction
In genome-wide association studies (GWAS), investigators collect genotypes and phenotypes from
a set of individuals and then perform a series of statistical tests to identify variants that are
significantly associated with the phenotype. Recently, the sample size for GWAS has increased to
tens of thousands or hundreds of thousands, and such large studies have newly discovered hundreds
of variants involved in multiple common diseases [42, 49]. Most of these variants have very small
effect sizes, emphatically supporting the message that the larger the association study the better
it fares in discovering associations.
Unfortunately, some phenotypes are either logistically difficult or very expensive to collect.
For these phenotypes, it is impractical to perform GWAS with tens of thousands or hundreds of
thousands of individuals. Examples of these phenotypes include ones that require obtaining an
inaccessible tissue such as brain expression, ones that require using a complex intervention such
as a response to diet, and ones that require re-contacting individuals simply because they were
unmeasured in the original cohort. For these phenotypes, investigators are often unable to collect
samples large enough to discover variants with small effect sizes. As a result, it is unlikely that
GWAS will be effectively conducted on these phenotypes.
One approach to increase power for GWAS on a phenotype that is hard to collect is utilizing
an intermediate or proxy phenotype that is correlated to the target phenotype of interest. In this
approach, one intermediate or proxy phenotype, which is highly correlated and easily collectable, is
collected and then GWAS is performed on the intermediate phenotype in order to detect associated
signals. For example, triglyceride levels can be collected as a proxy for obtaining information about
metabolic diseases. This approach is known as intermediate phenotype analysis [16, 33].
One way to interpret the intermediate phenotype analysis is to consider the target phenotype as
missing data and the use of intermediate phenotype as inferring the missing data. This connection
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to missing data analysis motivates the following intuition. In missing data analyses, it is well known
that utilzing multiple sources of information can be more effective than using a single source of
information, which has been shown in machine learning [2, 15, 29, 39, 45] and genetics [5, 7, 48].
This motivates an intuition that utilizing multiple phenotypes together as proxies for a trait can
lead to better performance, which is the basis of our approach.
In this paper, we propose an approach called phenotype imputation that allows one to perform
GWAS on a phenotype that is difficult to collect. In our approach, we leverage the correlation
structure between multiple phenotypes to impute the uncollected phenotype. Specifically, we esti-
mate the correlation structure from a complete dataset that includes all phenotypes, and use the
conditional distribution based on the multivariate normal (MVN) statistical framework to impute
the uncollected phenotype in an incomplete dataset. Because our imputation approach utilizes only
phenotypic information and not genetic information, imputed phenotypes can be subsequently used
for association test without incurring data re-use. For the situations that the final GWAS will in-
clude both the complete and incomplete datasets, we provide an optimal meta-analysis strategy
that combines association results from the collected phenotype and imputed phenotype while ac-
counting for imputation uncertainties. Moreover, we demonstrate that we can analytically calculate
the statistical power of association test using imputed phenotype, which can be helpful for study
design purposes. In addition, we show that the summary statistic of the imputed phenotype can
be approximated by a weighted linear combination of summary statistics for the proxy phenotypes.
This result makes our method applicable to datasets where we only have access to the summary
statistics and not the raw genotypes and phenotypes.
We show the effectiveness of our proposed approach by applying it to the Northern Fin-
land Birth Cohort (NFBC) data [41]. By imputing the triglycerides (TG), body mass index
(BMI), and systolic blood pressure (SBP) phenotypes, we recovered most of the significantly as-
sociated loci in the original data at the nominal significance level. This shows that even when
the imputed phenotype may not provide sufficient power for discovery purposes due to imputa-
tion uncertainties, it can effectively be used for replication purposes. Our method is available at
http://genetics.cs.ucla.edu/phenIMP.
3
2 Material and Methods
2.1 A Standard Genome-wide Association Study (GWAS)
We first describe the standard GWAS framework for testing genetic effects on quantitative phe-
notypes. Since the single nucleotide polymorphism (SNP) is the most common form of genetic
variation, throughout this paper, we consider SNPs. However, the frameworks can be generalized
to other types of variants. Suppose that we collect genotypes of m SNPs and ` quantitative pheno-
types for n individuals. Let Y indicate a (n× `) matrix of phenotypic values where Yk is a (n× 1)
vector for the k-th phenotype. Let yjk be the phenotypic value of the j-th individual for the k-th
phenotype and gji = {0, 1, 2} be the minor allele count of the j-th individual at the i-th SNP. Let
pi indicate the frequency of i-th variant in the population. In order to simplify the derivations,
we standardize the minor allele counts for each SNP to have a mean zero and a variance one,
such that xji ∈ { −2pi√
2pi(1−pi)
, 1−2pi√
2pi(1−pi)
, 2−2pi√
2pi(1−pi)
} represents the standardized value of gji. Let Xi
be the (n × 1) vector of standardized minor allele counts at the i-th SNP, where 1TXi = 0 and
XTi Xi = n. We assume Fisher’s polygenic model where the phenotype and the genotype follow
normal distributions. Under the additive model that each SNP contributes linearly towards the
phenotype:
Yk = µk1 +
m∑
i=1
βikXi + ek (1)
where µk is the phenotypic mean for the k-th phenotype, 1 is a (n× 1) vector of all ones, and βik
is the effect of the i-th SNP towards the k-th phenotype. ek ∼ N(0, σ2ekI) is the environment and
measurement errors where I is an identity matrix. We additionally assume that the phenotypes
are standardized so that their means are zero and their variances are one.
In a standard GWAS, we consider one SNP and one phenotype at a time. For notation clarity,
we omit SNP index below (e.g. instead of Xi, we use X). The following model is used to test each
SNP :
Yk = µk1 + βkX + ek (2)
Equation (2) is different from Equation (1) in that it omits the effects of the other SNPs, which can
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manifest as background genetic effects. This was the motivation of using mixed model [24, 27, 28, 54]
in the situations that sample data has population structures. Equation (2) leads us to least square
solutions, µˆk =
1TX
n and βˆk =
XTYk
XTX
, where “hat” over parameters denotes estimated values.
eˆk = Yk − µˆ1 − Xβˆk is the residual error which is used to compute the standard error σˆk =√
eˆTk eˆk
n−2 [17, 20, 21, 31]. Note that the estimated effect size is equal to the correlation between the
standardized minor allele counts and the standardized phenotypic values, βˆk = cor(X,Yk). If the
sample size is large enough, βˆk follows a normal distribution with the mean equal to the true effect
size βk. Thus, we can define a normally-distributed association statistic as sk =
βˆk
√
n
σˆk
. Under the
null hypothesis of no association (βk = 0), the statistic sk follows the standard normal distribution.
Under the alternative hypothesis of true association, the statistic sk follows a normal distribution
with non-centrality parameter (NCP) λ
√
n = βkσk
√
n [18, 20, 24, 54]:
sk =
βˆk
σˆk
√
n ∼
 N(0, 1) null hypothesis (no association)N(λ√n, 1) alternative hypothesis (3)
To reject the null hypothesis of no association, given the significance threshold α, we compute the
p-value, which is the probability that the observed statistic sk will be more extreme under the
null hypothesis, and determine that the association is significant if this probability is less than the
significance threshold α (e.g. α = 5× 10−8 in GWAS). Equivalently, we reject the null hypothesis
when Φ(sk) < αs/2 or Φ(sk) > 1 − αs/2, where Φ(.) indicates the cumulative density function of
the standard normal distribution.
The statistical power is the probability of detecting an association under the situation that an
association is present with a certain effect size [18, 35, 44, 46]. Intuitively, power measures the
probability that the truly associated variants will be discovered. Since statistical power depends on
both the effect size and the number of individuals in the study, power estimate can guide the choice
of study size as well as providing expectations on what effect sizes can and can not be discovered.
Given the effect size βk, its standard error σk, the number of individuals n, and the significance
threshold α, power is estimated as
P (α, βk, σk, n) = Φ(Φ
−1(α/2)− βk
σk
√
n) + 1− Φ(Φ−1(1− α/2)− βk
σk
√
n). (4)
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2.2 Phenotype Imputation
2.2.1 Phenotype Imputation Method
We consider two phenotype datasets in which we collected ` phenotypes from n1 and n2 individuals
respectively. Let Y(1) and Y(2) be matrices of phenotypic values of size (n1 × `) and (n2 × `),
and Y
(1)
k and Y
(2)
k be vectors of phenotypic values for the k-th phenotype in the first and second
datasets respectively. We use ¬` to indicate phenotypes excluding the `-th phenotype. Thus, y(1)j¬`
and y
(2)
j¬` are row vectors of the j-th individual phenotypes excluding the `-th phenotype in Y
(1)
and Y(2) respectively.
We assume the phenotypic values follow a multivariate normal distribution. In the discussion
section, we discuss the case where this assumption is violated. Assuming that each phenotype is
standardized to mean zero and variance one, we model the joint distribution of multiple phenotypes
as

y
(1)
j1
y
(1)
j2
...
y
(1)
j`

∼ N


0
0
...
0

,

1 r12 · · · r1`
r21 1 · · · r2`
...
r(`−1)1 r(`−1)2 · · · r(`−1)`
r`1 r`2 · · · 1


.
We can represent this more compactly with a block matrix:
y(1)Tj¬`
y
(1)
j`
 ∼ N
0,
Σ¬` R¬``
RT¬`` 1

 = N (0, H) ,
where y
(1)
j¬` is a row vector for the first (` − 1) phenotypic values for the j-th individual obtained
from Y(1) and y
(1)T
j¬` is the same vector in column format. Let rk1k2 indicate the correlation between
the two phenotypes k1 and k2, and let R¬`` = [r1`, r2`, · · · r`−1`]T denote a ((` − 1) × 1) vector
of correlations between Y
(1)
` and the phenotypes in Y
(1) excluding the `-th phenotype. Σ¬` is a
((`− 1)× (`− 1)) covariance matrix between the phenotypes in Y(1) excluding the `-th phenotype.
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Using the above joint distribution, we condition on y
(1)
j¬` phenotypes to compute the distribution
of phenotypic values for the j-th individual for the `-th phenotype. This distribution is computed
as follows:
(y
(1)
j` | y(1)j¬`) ∼ N
(
RT¬``Σ
−1
¬` y
(1)T
j¬` , 1−RT¬``Σ−1¬`R¬``
)
. (5)
In the phenotype imputation problem, we assume that the `-th phenotype is not collected in
the second study. Let Yˆ
(2)
` be the imputed phenotypic values for the uncollected phenotype. We
assume the correlation between any pair of phenotypes is the same in two datasets Y(1) and Y(2).
As a result, the above joint distribution in Equation (5) holds for Y(2). Thus, we can perform
similar conditional analysis. The conditional distribution is computed as follows:
(y
(2)
j` | y(2)j¬`) ∼ N
(
RT¬``Σ
−1
¬` y
(2)T
j¬` , 1−RT¬``Σ−1¬`R¬``
)
. (6)
To impute the missing phenotype for a particular individual j, we use the mean of the conditional
distribution as shown in Equation (6), RT¬``Σ
−1
¬` y
(2)T
j¬` , as our prediction. A more compact formula
to impute the `-th phenotype for all the individuals in the dataset Y(2) is as follows:
Yˆ` = Y
(2)
¬` Σ
−1
¬`R¬`` (7)
Equation (7) shows that the imputed phenotype is a linear weighted combination of other collected
phenotypes. Thus, if our multivariate normal assumption holds, the imputed phenotype will also
follow a normal distribution.
Utilizing the imputed phenotype in the association study, we compute the association statistic
of the imputed phenotype as the ratio between the estimated effect size for the imputed phenotype
and its standard error. The association statistic is:
sˆ` =
βˆ′`
σˆ′`
√
n2 =
XT Yˆ`
XTX√
eˆ
′T
` eˆ
′
`
n2−2
√
n2 (8)
where βˆ′`, σˆ
′
`, and eˆ
′
` are estimated effect size, standard error, and residual error computed from
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the imputed values of the `-th phenotype respectively. Given a sufficiently large sample size, this
statistic will follow a normal distribution. It will follow N (0, 1) under the null hypothesis of no
association to imputed phenotype.
2.2.2 Noisy Measurement Model
Here we introduce a model that is closely related to our phenotype imputation method. Under this
model, called noisy measurement model (NMM), our method has interesting optimal properties
that are related to the weighted sum of statistics approach. Note that, however, NMM is not a
requirement for our method to work.
Under NMM, we assume that the phenotype ` has the main genetic effect, and other phenotypes
can be modeled as the phenotype ` plus noise. That is, we consider the other phenotypes as noisy
measurements of the phenotype `. Under this model, obviously, the pleiotropic genetic effects to
other phenotypes are driven by the main genetic effect to phenotype `. As a result, the observed
genetic effect to each of ` − 1 phenotypes cannot be greater than the genetic effect to phenotype
`. This can be a strict assumption in general, but considering our situation that only phenotype `
is missing, this can be a reasonable assumption; if the genetic effect is greater in phenotype k 6= `,
such that it makes more sense to model the main effect driven by phenotype k, analyzing the
collected phenotype k data alone would be optimal, and we do not even need to perform phenotype
imputation.
Specifically, we describe NMM as
Y
(2)
k =
Y
(2)
` + uk√
1 + σ2uk
(9)
where uk is “noise” in the measurement. We assume that the noise follows a normal distribution
with mean zero and variance σ2uk , and further assume that the noise is independent from genotypes.
The denominator was formulated to standardize the phenotype Y 2k .
Let rk` be the correlation between Y
(2)
` and Y
(2)
k . It is straightforward to show that,
rk` =
√
1
1 + σ2uk
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Thus, we can re-write Equation (9) such as
Y
(2)
k = rk`(Y
(2)
` + uk) (10)
An important property of NMM is that if NMM holds, the strength of the effect of the variant
on phenotype k is approximately the strength of the effect of the variant on phenotype ` times
the correlation between the two phenotypes. That is, if s` ∼ N(λ√n2, 1), then approximately
sk ∼ N(rk`λ√n2, 1). This can be shown by,
sk =
XTY
(2)
k
XTX√
eˆTk eˆk
n2−2
rk`
√
n2 =
XTY
(2)
`
XTX√
eˆTk eˆk
n2−2
rk`
√
n2 +
uk
XTX√
eˆTk eˆk
n2−2
rk`
√
n2
= rk`
√
eˆT` eˆ`
eˆTk eˆk
s` +
uk
XTX
rk`√
eˆTk eˆk
n2−2
√
n2
sk ∼ N(r`kλ√n2, 1)
where we further assumed that the residual errors are similar for two phenotypes (eˆTk eˆk ≈ eˆT` eˆ`),
which holds true if the genetic effects are small. Note that a similar relationship arises when
considering the statistics of two SNPs in linkage disequilibrium (LD) and the correlation between
the two SNPs is r. It has been shown in various works [1, 12, 25, 38] the ratio between the NCPs
of two statistics is the same as r. This is similar to NMM in the sense that a causal SNP drives
the genetic effect, and the proxy SNP can be thought of as a noisy measurement of the causal SNP
due to LD.
2.2.3 Power of Phenotype Imputation
If NMM describes truth, it is possible to analytically calculate the power of our phenotype imputa-
tion method. Under NMM, we consider the situation that the variant we are testing is associated
with the `-th phenotype with NCP of λ
√
n2. As shown above, the NCP of the association statistic
for the k-th phenotype on the same variant is rk`λ
√
n2 where rk` is the correlation between the phe-
notypes k and `. Here, instead of considering the correlation between the phenotype ` and another
phenotype k, we consider the correlation between the phenotype ` and the imputed phenotype of
`.
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The covariance of the imputed and true phenotype is:
Cov(Yˆ`, Y`) = Cov(Y
(2)
¬` Σ
−1
¬`R¬``, Y
(2)
` ) = Cov(Y
(2)
¬` , Y
(2)
` )Σ
−1
¬`R¬`` = R
T
¬``Σ
−1
¬`R¬`` (11)
We know that the variance of Y
(2)
` is one, because we have already standardized the phenotypes.
We compute the variance of the imputed phenotype as follows:
Var(Yˆ
(2)
` ) = Var(Y
(2)
¬` Σ
−1
¬`R¬``) (12)
= RT¬``Σ
−1
¬` Var(Y
(2)
¬` )Σ
−1
¬`R¬``
= RT¬``Σ
−1
¬` Σ¬`Σ
−1
¬`R¬``
= RT¬``Σ
−1
¬`R¬``
Utilizing the covariance between the imputed and true phenotype and the variance of phenotypes,
we can compute the correlation as follows:
Cor(Yˆ
(2)
` , Y
(2)
` ) =
Cov(Yˆ
(2)
` , Y
(2)
` )√
Var(Yˆ
(2)
` )
=
√
RT¬``Σ
−1
¬`R¬`` (13)
Under NMM, each phenotype is modeled as a standardized linear combination of phenotype ` and
noise. Since imputed phenotype is also a linear combination of those phenotypes, we can consider
the imputed phenotype as a new phenotype that we can apply NMM. That is, we can consider the
imputed phenotype as a noisy version of the true phenotype. Then, by the property of NMM,
Cov(sˆ`, s`) =
√
RT¬``Σ
−1
¬`R¬`` = rimp
sˆ` ∼ N (
√
RT¬``Σ
−1
¬`R¬``λ
√
n2, 1) (14)
Since we obtained NCP of the statistic for imputed phenotype, we can analytically calculate power
of our phenotype imputation using Equation (4).
Note that the following quantity will have mean zero,
sˆ` − rimps` ∼ N(0, 1− r2imp) (15)
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The variance of sˆ` − rimps` is computed as follow:
Var(sˆ` − rimps`) = Var(sˆ`) + r2impVar(s`)− 2rimpCov(sˆ`, s`)
= 1 + r2imp − 2r2imp = 1− r2imp
In Results, we evaluate this quantity in real dataset, to evaluate if our imputation method works
as expected.
2.2.4 Relation to Optimal Linear Combinations of Marginal Statistics
The result of phenotype imputation is a weighted linear combination of the observed phenotypes.
Here, we show that under NMM, phenotype imputation is the “optimal” weighted combination of
the phenotypes in terms of statistical power. Let S¬` be a vector of association statistics computed
for the first ` − 1 phenotypes, S¬` = [s1, s2, · · · s`−1]T . Under NMM, given that the NCP of the
uncollected phenotype is λ
√
n2, we have S¬` ∼ N(R¬``λ√n2,Σ¬`). We calculate the association
statistic of the imputed phenotype as a linear combination of weighted statistics computed for the
(`−1) phenotypes. Let W = {w1, w2, · · ·w`−1} indicate the vector of weights where wi is the weight
corresponding to the i-th phenotype marginal statistics. Thus, we have:
W TS¬` ∼ N(W TR¬``λ√n2,W TΣ¬`W ) (16)
Using the above formula and the fact the variance of the associated statistic is one, we have:
sˆ` ∼ N ( W
TR¬``√
W TΣ¬`W
λ
√
n2, 1)
It has been shown, power is maximized when we maximize the NCP [13]. Thus, we find the set of
weights which maximizes W
TR¬``√
WTΣ¬`W
. Let ATA = Σ¬` and W ′ = AW , our maximization problem
reduces to following optimization:
argmax
W ′
W ′TAΣ−1¬`R¬``√
W ′TW ′
.
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Let Θ = AΣ−1¬`R¬``. Using the Cauchy-Schwarz inequality, we have
`−1∑
j=1
w′jθj ≤
√√√√`−1∑
j=1
w′2j
√√√√`−1∑
j=1
θ2j .
The optimal value for W ′ is Θ and the maximum NCP is as follows:
√
RT¬``Σ
−1
¬`R¬``λ
√
n2.
This is exactly the NCP obtained from the previous section. Moreover, the optimal value for W is
Σ−1¬`R¬`` which is the same vector of weights used in the previous section. This is the justification
for Equation (14) above.
Interestingly, this result indicates we can use Equation (16) and the optimal weights, which are
obtained in this section, to estimate the marginal statistics of the imputed phenotype as weighted
linear combinations of observed marginal statistics from other phenotypes. Thus, given the observed
marginal statistics of the first (`− 1) phenotypes and the pairwise phenotype correlations, we can
compute the estimated marginal statistics. Our method does not need to have access the raw
genotypes and phenotypes. This makes our method applicable to datasets for which we only have
access to the summary statistics.
We note that for any vector of weights, including the ones utilized in imputation, the type I
error rates are controlled. This is because if the variant we are testing is not associated with the
phenotype, λ = 0, then the NCP of the imputed statistic for that variant is zero.
2.2.5 Optimal Meta-Analysis Strategy for Combining Imputed and Observed Values
We use the phenotype imputation to fill the values of the phenotype for individuals whose pheno-
typic values are missing. We then want to obtain an association statistic for the combined dataset
including the imputed and observed phenotypes. However, since our imputation is not always accu-
rate, utilizing both observed and imputed data together without distinguishing them is suboptimal.
We propose to compute the association statistics by performing statistical tests on the collected
phenotype and imputed phenotype separately. Then, we perform a fixed-effect meta-analysis to
combine the two statistics.
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We use Ym and Yc to indicate the missing and collected phenotypes respectively. We compute
the association statistic of each set separately. The association statistic for the collected phenotype
is computed as sc ∼ N (λc√nc, 1) where λc is the NCP of the phenotype and nc is the number
of individuals whose phenotypic values are collected for this phenotype. We use Equation (14) to
compute the z-score for the imputed phenotype as sˆm ∼ N (
√
RT¬``Σ
−1
¬`R¬``λc
√
nm, 1) where nm is
the number of individuals whose phenotypic values are missing for this phenotype.
We combine the two statistics using the fixed-effects meta-analysis. The fixed-effects meta-
analysis association statistic, sFE , is computed as sFE =
wcsc+wmsˆm√
w2c+w
2
m
, where wc and wm are com-
puted such that the meta-analysis association statistic is maximized [11, 50]. As shown in previous
studies [11, 51] the optimal weights are computed as wc =
√
nc and wm =
√
RT¬``Σ
−1
¬`R¬``nm.
Thus, we have:
sFE =
√
ncsc +
√
RT¬``Σ
−1
¬`R¬``nmsˆm√
nc +RT¬``Σ
−1
¬`R¬``nm
(17)
Using Equation (17), we combine the statistics computed for the collected phenotype and imputed
phenotype as a joint association statistic.
2.2.6 Polygenic Model
We described the properties of our method under NMM. However, NMM is a simple model and
may not always hold true. Here we introduce a more complex model, which explicitly models both
the genetic and environmental correlations in phenotypes. We suggest a strategy that is optimized
for this model, and we show that the new strategy is equivalent to our standard strategy under
some simplifying assumptions.
Let B = {β1, β2, · · ·β`} indicate the vector of true effect sizes of a given variant towards all `
phenotypes where βj is the effect size for the j-th phenotype. Let E be a (n × `) matrix which
models the errors. We consider a multi-phenotype setting, where we perform a join testing of a
variant for all the ` phenotypes:
13
vec(Y) = (I ⊗X)B + vec(E)
where vec() is an operator that converts a matrix to vector by stacking columns of matrix and ⊗
is an operator that performs Kronecker product between two matrices.
Given this multi-phenotype setting, we can model the genetic and environmental correlations.
Let ρij and ξij indicate the genetic and environment correlations, respectively, between i-th and
j-th phenotype. Let σ2gi denotes the genetic variance of phenotype i. Let σ
2
ei denotes the error
variance of phenotype i. In the multi-phenotype polygenic model, the true vector of effect sizes are
assumed to follow a MVN [14, 52–54], such that

β
(1)
1
β
(1)
2
...
β
(1)
`

∼ N


0
0
...
0

,
1
m

σ2g1 ρ12σg1σg2 · · · ρ1`σg1σg`
ρ21σg1σg2 σ
2
g2 · · · ρ2`σg2σg`
...
ρ`1σg`σg1 ρ`2σg`σg2 · · · σ2g`


= N (0, 1
m
G) (18)
where 1m is the proportion that the variant contributes to the genetic variance [14, 52–54]. Here,
we assumed that 1m is the same for all phenotypes. In the similar way, we define a (`× `) variance
matrix that encodes the environmental correlations,
Υ =

σ2e1 ξ12σe1σe2 · · · ξ1`σe1σe`
ξ21σe1σe2 σ
2
e2 · · · ξ2`σe2σe`
...
ξ`1σe`σe1 ξ`2σe`σe2 · · · σ2e`

Under the polygenic model, we have Cov(Yi, Yi) = σ
2
giK + σ
2
eiI and Cov(Yi, Yj) = ρijσgiσgiK +
ξijσeiσejI whereK is the kinship matrix that represents the genetic relatedness between individuals.
We use a (`n×`n) matrix that encodes the covariance for all pairs of phenotypes and let V represent
this covariance matrix:
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V =

Cov(Y1, Y1) Cov(Y1, Y2) · · ·Cov(Y1, Y`)
Cov(Y2, Y1) Cov(Y2, Y2) · · ·Cov(Y2, Y`)
...
Cov(Y`, Y1) Cov(Y`, Y2) · · ·Cov(Y`, Y`)

= G⊗K + Υ⊗ I
Let Bˆ indicate the vector of estimated effect sizes for all the ` phenotypes for a given variant.
Using the mixed model we have Bˆ = ((I ⊗ X)TV −1(I ⊗ X))−1(I ⊗ X)TV −1Y and Var(Bˆ) =
((I ⊗ X)TV −1(I ⊗ X))−1 = Ψ. Let ψij be the ith row and jth column element of Ψ. We can
compute the joint distribution of marginal statistics for all the ` phenotypes. Let S = {s1, s2, · · · s`}
indicate a (` × 1) vector of marginal statistics. The joint distribution of statistics follows a MVN
which is as follows:
S ∼ N


β1
ψ11
...
β`
ψ``
 ,

1 ψ12√
ψ11ψ22
· · · ψ1`√
ψ11ψ``
ψ21√
ψ11ψ22
1 · · · ψ2`√
ψ22ψ``
...
ψ`1√
ψ``ψ11
ψ2`√
ψ``ψ22
· · · 1


= N (Λ,Γ) (19)
where Λ is the vector of NCPs. Note that using Equation (18), we can assume a prior distribution
for effect size of the single SNP that we test, such as B ∼ N (0, 1mG). Since NCP is true effect size
normalized to have variance one, prior distribution for B gives us prior distribution for NCP,
Λ ∼ N

0,
1
m

σ2g1
ψ11
ρ12σg1σg2√
ψ11ψ22
· · · ρ1`σg1σg`√
ψ11ψ``
ρ21σg2σg1√
ψ11ψ22
σ2g2
ψ22
· · · ρ2`σg2σg`√
ψ22ψ``
...
ρ`1σg`σg1√
ψ``ψ11
ρ`2σg`σg2√
ψ``ψ22
· · · σ
2
g`
ψ``


= N (0,Ω) (20)
In summary, we have S ∼ N (Λ,Γ) and Λ ∼ N (0,Ω). We assume the NCP for the `-th phenotype
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is λ
√
n2. Thus, the NCPs of the phenotypes excluding, the `-th phenotype is as follows:
Λ¬` ∼ N (ΩT¬``Ω−1`` λ
√
n2,Ω¬`¬` − Ω¬``Ω−1`` ΩT¬``) (21)
In similar way, the marginal statistics of all the phenotypes excluding the `-th phenotype is as
follows:
S¬` ∼ N (ΩT¬``Ω−1`` λ
√
n2,Ω¬`¬` − Ω¬``Ω−1`` ΩT¬`` + Γ¬`¬`) (22)
To simplify above equation, we can set the Λ¬` to the mean of Equation (21). This assumption
implies that the marginal statistics of all the phenotypes excluding, the `-th phenotype is as follows:
S¬` ∼ N (ΩT¬``Ω−1`` λ
√
n2,Γ¬`¬`) (23)
Similar to previous section, we consider the imputed marginal statistics is a weighted linear combi-
nation of all the marginal statistics that maximizes the power. Using Cauchy-Schwartz inequality,
we can show that the maximum NCP of sˆ` will be
√
Ω−1`` Ω
T
¬``Γ
−1
¬`¬`Ω¬``Ω
−1
`` λ
√
n2. The maximum
NCP is achieved when the weights of the marginal statistics are Γ−1¬`¬`Ω¬``Ω
−1
`` . Therefore, we
have successfully derived the weighted combination of marginal statistics that is optimized for the
polygenic model.
2.2.7 Relation Between Polygenic Model and Noisy Measurement Model
We show that under some simplifying assumptions, the method for polygenic model is equivalent
to the standard method for NMM. We make two assumptions that the pairwise genetic and envi-
ronment correlations are equal (e.g. ρij = ξij) and that the individuals are sufficiently unrelated
that we can approximate K with I. The second assumptions implies that we have no population
structure. Given these two assumptions, we can simplify V which is as follows:
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V =

(σ2g1 + σ
2
e1)I (ρ12σg1σg2 + ξ12σe1σe2)I · · · (ρ1`σg1σg` + ξ1`σe1σe`)I
(ρ21σg2σg1 + ξ21σe2σe1)I (σ
2
g2 + σ
2
e2)I · · · (ρ2`σe2σg` + ξ2`σe2σe`)I
...
(ρ`1σg`σg1 + ξ`1σe`σe1)I (ρ`2σ`1σg2 + σe`σe2)I · · · (σ2g` + σ2e`)I

= H ⊗ I
(24)
where σ2gi + σ
2
ei = 1 for any phenotypes as we standardized the phenotypes and H is phenotypic
correlation matrix. Thus, Var(Bˆ) =
(
(I ⊗X)T (H ⊗ I)−1(I ⊗X))−1 = 1n2H. As a result, we have
Λ ∼ N
(
0, 1mn2H
)
. Given the NCP for the `-th phenotype is λ
√
n2 then the NCPs of all the pheno-
type excluding the `-th phenotype will have a distribution with mean equal to R¬``λ
√
n2. Similar
to previous section, if we fix NCP to its mean value for simplification, the method converges to the
standard approach based on NMM. This result implies that considering the two assumptions men-
tioned above, our approach for the multi-phenotype polygenic model is equivalent to the standard
strategy for NMM.
2.2.8 Avoiding Over-fitting
In some datasets, such as eQTL datasets, the number of phenotypes is large (` is large). Thus, we
have the risk of over-fitting. Over-fitting occurs in a method where the number of parameters is
large. As the method usually does not generalize, it produces very high accuracy in the training
dataset and very low accuracy in the test dataset. One way to avoid over-fitting, we can add a
sparsity prior such as the Laplace prior [37] which reduces the linear regression to LASSO [47]. In
the LASSO setting, we impute the phenotype while utilizing few phenotypes to avoid over-fitting.
Another solution is to select the most informative phenotypes and then apply our method. As an
example, we can pick the top 10 phenotypes based on their correlation with the target phenotype.
We only use these 10 phenotypes in our method.
17
2.2.9 Handling Missing Data
Our method can handle missing data in the target dataset by performing imputation with only the
available phenotypes for each individual. In this scenario, some of the individuals will have more
accurate imputation than others because they utilize more phenotypes to perform the imputation.
We have developed an optimal approach for performing association test utilizing these differing
degrees of quality of phenotype imputation, which we detail in the Supplementary Materials.
2.2.10 Utilizing Covariates
In a typical GWAS, we usually adjust for the non-genetic factors that influence the phenotype,
such as sex, age, study design, and known clinical covariates. Covariate adjustment reduces the
spurious association signals in a study. Given, we have p covariates, we need to adjust for them
by extending the Equation (1). Thus, the polygenic model used to handle covariates for the k-th
phenotype is as follows:
Yk = µk1 +
m∑
i=1
βikXi +
p∑
i=1
γikZi + ek (25)
where Zi is the i-th covariate and γik is the effect of that covariate towards the k-th phenotype.
Moreover, to perform the single SNP association test instead of using Equation (2), we need to
adjust for the covariates. We use the following model for the single SNP association test:
Yk = µk1 + βkX +
p∑
i=1
γikZi + ek (26)
There are two possible ways to adjust for covariates for phenotype imputation. First possible way is
to impute the phenotype and then use Equation (26) for asscoation testing. This testing is similar
for testing collected phenotypes and adjusting for covariates. Second possible way is to regress out
the covariates from all the collected phenotypes to generate new phenotypes where the covariates
are removed. Then, we use our imputation method to impute the uncollected phenotype using the
phenotypes which the covariates are regressed out. In this case, we can use Equation (2) to perform
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asscoation testing.
3 Results
3.1 Overview of Phenotype Imputation
In phenotype imputation, we consider two datasets (D1, D2), in which multiple phenotypes are
collected along with genetic information to perform GWAS. In the first dataset (D1), we collect the
target phenotype and the related phenotypes. In the second dataset (D2), the related phenotypes
have been collected for all of the individuals but the target phenotype has not been collected.
Given these datasets, we predict the uncollected target phenotype in the second dataset (D2) by
leveraging the correlation structure between the additional phenotypes and the target phenotype.
We use the first dataset (D1) to approximate this correlation structure. After imputing the target
phenotype, we perform GWAS to discover genetic variants that are significantly associated with
the imputed target phenotype.
Our framework allows for the estimation of the relative power of imputation compared to the
power if the phenotype was collected in the sample. Intuitively, the power loss depends on how
close the imputed phenotypes are to the true phenotypes. We define the correlation between the
imputed and true phenotypes as rimp and we can estimate rimp from only the first dataset. This
allows us to have an idea of how well the imputation will perform in the target dataset. Under
some additional assumptions, which we refer to as the noisy measurement model (NMM), the
power in the imputed study with n individuals is equivalent to the power of a complete study
where r2impN individuals were collected (see Methods for the detailed derivation). We define the
number of individuals that contribute toward the power of a statistical test for a phenotype as the
effective number of individuals. For example, we can impute triglycerides (TG) levels in the NFBC
dataset [41] using high-density lipoproteins (HDL), low-density lipoproteins (LDL), and systolic
blood pressure (SBP) with a correlation of 0.5. As a result, in a study where we collect HDL, LDL,
and SBP for 8,000 individuals, the power of GWAS on the imputed TG is equivalent to performing
GWAS in 2,000 individuals where TG has been collected.
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Phenotype rsID Real test data 1 Imputed test data |Zimp-rimp*Zreal|
β se(β) Z-score (Zreal) P-value β se(β) Z-score (Zimp) P-value
TG
rs3923037 0.074 0.0149 4.96 7.14e-07 0.0224 0.0083 2.700 0.006 0.17
rs6728178 0.076 0.0149 5.10 3.45e-07 0.0267 0.0083 3.209 0.001 0.24
rs6754295 0.074 0.0149 4.94 7.91e-07 0.0266 0.0083 3.197 0.001 0.32
rs676210 0.0752 0.0149 5.01 5.38e-07 0.0250 0.0083 2.996 0.002 0.084
rs673548 0.0762 0.0149 5.08 3.81e-07 0.02530 0.0083 3.031 0.002 0.08
rs1260326 -0.0807 0.0150 -5.37 8.15e-08 -0.004 0.0084 -0.534 0.59 2.58
rs10096633 0.0819 0.0147 5.55 3.00e-08 0.0191 0.0082 2.324 0.02 0.79
BMI
rs987237 -0.074 0.0150 -4.97 6.63e-07 -0.037 0.00929 -4.07 4.62e-05 0.93
rs11759809 -0.074 0.0150 -4.95 7.35e-07 -0.036 0.00931 -3.96 7.43e-05 0.84
SBP
rs782586 0.074 0.0149 4.96 7.43E-07 0.036 0.01016 3.50 0.00047 0.37
rs782588 0.074 0.0149 4.94 8.14E-07 0.035 0.01014 3.43 0.00061 0.32
rs782602 0.075 0.0150 5.01 5.53E-07 0.034 0.01016 3.39 0.00071 0.23
rs2627759 0.070 0.0150 4.65 3.44E-06 0.032 0.01016 3.12 0.00183 0.19
rs10486523 -0.073 0.0145 -4.98 6.62E-07 -0.031 0.00999 -3.08 0.00207 0.06
rs9791555 -0.073 0.0145 -4.97 6.79E-07 -0.031 0.00999 -3.07 0.00214 0.06
rs7799346 -0.073 0.0145 -4.98 6.52E-07 -0.030 0.00999 -3.04 0.00235 0.09
rs6976779 0.069 0.0146 4.71 2.59E-06 0.039 0.01000 3.94 0.00008 0.97
rs2846572 -0.067 0.0145 -4.62 3.94E-06 -0.031 0.00998 -3.10 0.00194 0.19
Table 1: Comparison between the association test on the real test data for TG, BMI, and SBP phenotypes
and the imputed test data in the NFBC data. Zimp and Zreal are the test statistics (Z-score) obtained from
the imputed and original datasets respectively. The last column is the difference between the imputed test
statistics and the analytical test statistics.
3.2 Phenotype Imputation Controls Type I Error
We simulated datasets for multiple phenotypes under the null model where the variant we are
testing has no effect (effect size of zero) towards the target phenotype. We computed the type
I error under five different significance thresholds: 0.05, 0.01, 0.005, 5×10−6, and 5×10−8. We
generated 100,000,000 simulated datasets which consist of 1000 individuals. The type I error
rates for our imputation method were 0.049, 0.0099, 0.00489, 4.90×10−6, and 4.89×10−8 for the
significance thresholds of 0.05, 0.01, 0.005, 5×10−6, and 5×10−8, respectively. This indicates that
the type I error is correctly controlled in our imputation method. Using the Northern Finland
Birth Cohort dataset [41] we show that the type I error is controlled (see Figure S.1). We plot
the Q-Qplot of the z-score for the imputed triglycerides (TG) phenotype from the Finland dataset.
There is no inflation in the Q-Qplot shown in Figure S.1
1The real test data is obtained from the NFBC data by removing the 500 individuals who are assumed to be
missing in our experiment.
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3.3 Phenotype Imputation on Northern Finland Birth Cohort (NFBC)
In order to assess the performance of our method, we utilize the Northern Finland Birth Cohort
(NFBC) dataset [41]. The NFBC dataset consists of 10 phenotypes collected from 5,327 individuals.
The 10 phenotypes are triglycerides (TG), high-density lipoproteins (HDL), low-density lipoproteins
(LDL), glucose (GLU), insulin (INS), body mass index (BMI), C-reactive protein (CRP) as a
measure of inflammation, systolic blood pressure (SBP), diastolic blood pressure (DBP), and height.
The genotype data consists of 331,476 SNPs. Figure 1 shows the pairwise correlations between each
pair of phenotypes. The correlation coefficients between the phenotypes in this data are between
0.01-0.62. SBP and DBP are the two phenotypes that show the highest correlation.
Figure 1: The pairwise correlation between each pair of phenotype in the NFBC dataset.
We consider the possibility of imputing each of these 10 phenotypes using the other nine phe-
notypes. We first compute the corresponding value of rimp (Table S.1). In order to evaluate our
method, we are interested in the scenario where rimp is high and higher than the highest pairwise
correlation. Among these 10 phenotypes the TG, INS, DBP, BMI and SBP are the phenotypes
that satisfy these criteria. Since INS and DBP have no significantly associated variants, we focus
on TG, BMI, and SBP phenotypes for our evaluation.
For our experiments, we assume that TG, BMI and SBP phenotypes are only collected for
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500 individuals which are used as a training dataset to estimate the correlation structure between
phenotypes. We mask the TG, BMI and SBP phenotypic values in the rest of the individuals
and only use them when we measure the imputation accuracy. We utilize the 500 individuals to
compute the correlation structure between the phenotypes, and we use our method to impute the
TG, BMI and SBP phenotypes for the other individuals.
The correlation between the imputed phenotype and the true TG phenotypes is rimp = 0.58.
Our estimate of this correlation from the training data is rˆimp = 0.58. This correlation coefficient
and the size of the data results in an effective number of individuals being ∼1620 (0.582× (5, 327−
500) = 1623). For this reason, we do not expect to see any significant loci in our imputed data.
However, this size of data is enough to observe an effect in the context of a replication study.
We perform association analysis using EMMAX [24] in the imputed phenotypes, and also utilizing
the original TG phenotypes for comparison. Table 1 shows the estimated effect size(β), standard
error of the estimated effect size (se(β)), Z-scores, and p-values. The result in Table 1 indicates
that when we run EMMAX [24] on the original TG phenotype in the test dataset, we have seven
loci that pass our significance threshold of 5 × 10−6. When we run EMMAX [24] on the imputed
phenotypes for these seven loci, we observe that most of these loci (six out of seven loci) pass the
replication significance threshold of at least 0.05. Therefore, it appears that for most variants,
phenotype imputation power is equivalent to collecting r2impn individuals. Surprisingly, the test
statistic (Z-score) for the imputed phenotype of all variants other than rs1260326 is close to rimp
times the test statistic (Z-score) at the actual variant as shown in the last column of Table 1.
We define two statistics are close when the difference between the two statistics is less than one
standard deviation (the standard deviation is 1). This is exactly the result we expect under NMM.
We also expect that if the assumption holds, the distribution of the statistic on the imputed data
minus rimp times the statistic on the original data (last column of Table 1) over the whole data will
follow a distribution with mean 0 and variance 1 − r2imp as described in the methods. In Figures
2, S.3, and S.4, we show that this is the case for the TG, BMI and SBP phenotypes respectively.
This shows that although NMM is a simple model, NMM describes these datasets effectively. This
result shows that performing GWAS on the imputed phenotype has enough power to identify most
of the associated loci that are significant when we perform GWAS on the original phenotype.
We further investigate rs1260326 whose imputed z-score was not close to the expected value.
22
D
en
si
ty
−4 −2 0 2 4
0.
0
0.
1
0.
2
0.
3
0.
4
Figure 2: Difference between the imputed marginal statistics and analytical marginal statistics for TG
phenotype. Imputed marginal statistics is obtained from the association between the genotype and the
imputed phenotype and analytical marginal statistics is equal to the marginal statistics computed on the
true target phenotype scaled by rimp. The blue curve is the normal distribution with mean zero and variance
1-r2imp. This histogram indicates this difference follows a normal distribution (mean zero and variance 1-
r2imp). Thus, for most null variants the NMM assumption holds.
Table S.2 shows the EMMAX [24] results for rs1260326 on all of the phenotypes in the NFBC data.
We observe that in the original data this SNP is only significant for the TG phenotype. Thus, the
effect sizes of this SNP for multiple phenotypes are not well modeled by the overall phenotypic
correlation. For this reason, our method and any other possible approaches that will use proxy
phenotypes, will have limited performance in detecting such a locus.
3.4 Phenotype Imputation on Hybrid Mouse Diversity Panel (HMDP)
We also apply our method to the Hybrid Mouse Diversity Panel (HMDP) collected in Bennett et
al. (2010) study [6]. The Bennett et al. (2010) study consists of 25 phenotypes, 894 animals, and
98 strains. In this experiment, we impute body fat (BF) mass, which we consider as the target
phenotype, by utilizing metabolic phenotypes (HDL, TG, TC, UC, FFA, and GLU) as the related
phenotypes. The BF phenotype is measured by nuclear magnetic resonance (NMR). We assume
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the BF phenotype is collected for only 200 animals, which is used as a training dataset to compute
the pairwise correlations (see Figure S.6). The correlation between the imputed phenotype and the
true BF phenotype is rimp = 0.4. We perform similar experiments for this study to those performed
on the TG phenotype for the NFBC dataset. Table 2 indicates the significant SNPs which pass our
significant threshold of 0.05 for both imputed and real test datasets. This result indicates results
similar to the NFBC dataset. For all of the variants the test statistic (Z-score) for the imputed
phenotype is close to rimp times the test statistic (Z-score) at the actual variant as shown in the
last column of Table 2.
rsID Real test data Imputed test data |Zimp - 0.4 * Zreal|
β se(β) Z-score (Zreal) P-value β se(β) Z-score (Zimp) P-value
rs38946050 -0.247 0.05887 -4.200 3.04E-05 -0.093 0.03220 -2.891 0.003 1.211
rs37558901 -0.163 0.03803 -4.286 2.09E-05 -0.051 0.0209 -2.448 0.01 0.733
rs27178379 -0.185 0.04433 -4.176 3.36E-05 -0.055 0.02435 -2.275 0.02 0.604
rs50810977 -0.163 0.03803 -4.286 2.09E-05 -0.051 0.0209 -2.448 0.01 0.733
rs51148868 -0.185 0.04433 -4.176 3.36E-05 -0.055 0.02435 -2.275 0.02 0.604
rs32339557 -0.163 0.03803 -4.286 2.09E-05 -0.051 0.02093 -2.448 0.01 0.733
rs51646366 -0.163 0.03803 -4.286 2.09E-05 -0.051 0.02093 -2.448 0.01 0.733
rs31560659 -0.163 0.03803 -4.286 2.09E-05 -0.051 0.02093 -2.448 0.01 0.733
rs50923350 -0.163 0.03803 -4.286 2.09E-05 -0.051 0.02093 -2.448 0.01 0.733
rs37193394 -0.205 0.04742 -4.331 1.72E-05 -0.056 0.02599 -2.161 0.03 0.428
rs26890141 -0.185 0.04433 -4.1769 3.36E-05 -0.055 0.02435 -2.275 0.02 0.604
rs46913800 -0.185 0.04433 -4.1769 3.36E-05 -0.055 0.02435 -2.275 0.02 0.604
rs38214662 -0.163 0.03803 -4.2867 2.09E-05 -0.051 0.02093 -2.448 0.01 0.733
rs47384543 -0.185 0.04433 -4.1769 3.36E-05 -0.055 0.02435 -2.275 0.02 0.604
rs51585751 -0.163 0.03803 -4.2867 2.09E-05 -0.051 0.02093 -2.448 0.01 0.733
rs29268223 -0.185 0.04433 -4.1769 3.36E-05 -0.055 0.02435 -2.275 0.02 0.604
Table 2: Comparison between the association test for BF phenotype on the real test data and the imputed
test data in the HMDP.
3.5 Evaluating Imputation Power by Simulation
We evaluate the power of phenotype imputation through simulations. We remove the phenotype
of interest from the dataset, then apply phenotype imputation to predict its value and measure
the corresponding association power after imputation. In order to robustly measure this power, we
randomize the individuals from whom we remove phenotype values.
Specifically, we follow the following simulation procedure. We consider a locus that has a
significant association. In the first step, we compute the number of individuals that we need to
remove their phenotypic values to obtain the statistical power of 50% for that locus. Let k indicate
the number of individuals obtained from this step. In the second step, we randomly choose k
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individuals and consider the phenotypic values for these k individuals that are missing. Then, we
use our imputation model to impute the phenotypic values of these k individuals. We perform
association test on the complete dataset. We repeat the second step 10,000 times in order to
compute the statistical power. We compute the statistical power as the number of times where
the computed association statistic is significant (with p < 10−6). If the imputation is working, we
would expect to see an increase in the power over 50%. We refer to the statistical power of 50% as
the statistical power before imputation. We compute the value of k in the first step by randomly
removing phenotypes of k individuals for 10,000 simulations. Then, for this value of k, we check
whether the number of simulations where the association statistics is significant (with p < 10−6) is
5,000 (50% of total simulations that corresponds to statistical power of 50%). We use TG, BMI,
and SBP phenotypes from NFBC data to perform the power simulation. As shown in Table 3, the
power gained by imputing the missing phenotype is 8%− 33%.
Phenotype rsID Power Power Absolute power gain
after imputation before imputation
TG
rs673548 83.59% 50% 33.59%
rs10096633 62.16% 50% 12.16%
rs3923037 63.74% 50% 13.74%
rs6728178 80.97% 50% 30.97%
rs6754295 76.40% 50% 26.40%
rs676210 82.16% 50% 32.16%
BMI
rs987237 63.12% 50% 13.12%
rs11759809 61.33% 50% 11.33%
SBP
rs782586 82.52% 50% 32.52%
rs782588 81.72% 50% 31.72%
rs782602 81.99% 50% 31.99%
rs2627759 74.05% 50% 24.05%
rs9791555 58.77% 50% 8.77%
rs7799346 58.63% 50% 8.63%
Table 3: Measuring power of imputation by simulation in the NFBC data.
In the method section, we provide an optimal weight to combine imputed and observed sum-
mary statistics in a fixed effect meta-analysis. This process is beneficial when we have access to
the summary statistics. We utilize the same simulation process described above. We randomly
pick k individuals to mask them as individuals with missing phenotypes. Then, we compute the
summary statistics (sc) for individuals whose phenotypic values are observed. We impute the miss-
ing phenotypes and compute the summary statistics (sˆm) for individuals whose phenotypic values
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are missing. To combine these statistics, we have two options. First option, we use Equation
(17) to combine the computed summary statistics in an optimal way. We refer to this option as
imputation-based fixed-effect meta-analysis. Second option, we use fixed effect meta-analysis with
typical fixed-effect meta-analysis weights. In this case, we use wc =
√
nc and wm =
√
nm. We refer
to this option as general fixed-effect meta-analysis. We observe that, using the second option in
which the weights are not optimal, we have loss of power (see Table 4). Moreover, we compare
the first option, which is optimal, to the previous simulations where we combine the imputed and
observed phenotypic values. Finally, we compute the summary statistics. We observe there is a
small difference between these two cases. In this experiment we use TG phenotype from NFBC
dataset.
rsID Imputation-based Fixed-effect Meta-analysis General fixed-effect meta-analysis
Power Power
rs673548 83.56% 82.30%
rs10096633 62.14% 45%
rs3923037 63.65% 60.86%
rs6728178 80.96% 80.00%
rs6754295 75.49% 74.31%
rs676210 82.01% 80.85%
Table 4: The optimal meta-analysis strategy to combine summary statistics for imputed and observed
phenotype achieves maximum power. Imputation-based Fixed-effect Meta-analysis uses the optimal weights
that is shown in Equation (17). General fixed-effect meta-analysis uses the typical fixed-effect meta-analysis
weights where the weight for each study is square root of the number of samples in that study.
The statistical power of imputation depends on rimp which is the correlation between the im-
puted and true phenotype (see Figure 3). We use similar experiments as described above. We con-
sider imputing TG phenotype using HDL, LDL, CRP, and GLU phenotypes. There are 24−1 = 15
possible combinations for these four phenotypes to impute the TG phenotype (excluding one com-
bination that refers to a case where none of the four phenotypes are used for imputation). For
each combination of phenotypes, we compute rimp and the statistical power for a given variant. In
Figure 3, the black circle indicates one of the 15 possible combinations for imputing TG pheno-
type. The x-axis is the computed rimp for a given combination of phenotypes, and the y-axis is the
computed statistical power. The red curve indicates a second order polynomial that is fitted to the
black circles. We observe that the statistical power increases as we increase the value of rimp (see
Figure 3). There are two factors that increase rimp. First factor to increase rimp is the number
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of phenotypes that satisfies the NMM assumption. As we use more phenotypes that satisfy the
NMM assumption in our imputation method, we can increase rimp that result in increases of power.
Second factor to increase rimp is the correlation between phenotypes that are used to impute target
phenotype. As we use more correlated phenotypes, we can increase rimp that result in increases of
power.
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Figure 3: Increase of rimp increases the statistical power. The x-axis is the rimp and the y-axis is computed
power. Panels (a), (b), (c), and (d) illustrate the effect of rimp on power of imputing the TG phenotype for
rs6728178, rs673548, rs6754295, and rs676210, respectively. We impute the TG phenotype in NFBC data
using HDL, LDL, CRP, and GLU phenotypes. The black circle indicates the rimp and the statistical power
for a combination of four phenotypes to impute TG for one variant. The red curve indicates a second order
polynomial which is fitted to the black circles.
3.6 Utilizing Simulation Data to Validate Our Model
In the method section, we show the rimp, which is the correlation between imputed and true pheno-
type, is equal to
√
RT¬``Σ
−1
¬`R¬``. We impute one of the phenotypes by utilizing any combination of
the remaining nine phenotypes. There are 29 − 1 possible combinations for these nine phenotypes
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to impute the desired phenotype in NFBC dataset. We compute the difference between rimp and√
RT¬``Σ
−1
¬`R¬``. We observe that this difference is small (see Figure S.5). We compute rimp as
a correlation between imputed and true phenotype. We perform this experiment for all the nine
phenotypes (TG, HDL, LDL, BMI, CRP, GLU, INS, SBP, and DBP) in NFBC dataset.
Next, we compare the difference between the computed association statistics for imputed phe-
notype and the analytical association statistics obtained from Equation (14). We simulated pheno-
types for 1,000, 5,000, and 10,000 individuals and we considered three, four, five, and six phenotypes
in each simulation. We simulate multi-phenotypes utilizing the matrix-variate that is used in previ-
ous works [14, 52–54]. We run each of the simulations for 10,000 times and our result is the average
of 10,000 runs. The result of these simulations are shown in Table S.3.
4 Discussion
We propose a novel method for the problem of phenotype imputation. The primary advantage
of our framework is it increases power of GWAS on phenotypes that are difficult to collect. We
provide an analytical power computation that allows researchers to prospectively determine the
benefit of the imputation for a given dataset. Another advantage of our method is that it allows
the use of summary statistics when the raw genotypes are not available.
Our model assumes that the phenotypes follow a normal distribution. This assumption is widely
accepted in the GWAS community [20, 24, 54]. When the phenotypes are not normal, one possible
way is to transform the phenotypes to follow a normal. In our case, we applied the inverse normal
transform to the data which is heavily used by many studies [3, 36, 43] and verified that when all of
the phenotypes in the NFBC data were transformed, the phenotypes as a set followed a multivariate
normal distribution (see Figure S.2). Another possible way to deal with non-normal phenotypes
is to use the weighted combination of statistics approach. Asymptotically, the multivariate central
limit theorem applies if the datasets are large enough and the statistics themselves will follow a
multivariate normal distribution. Thus, using weighted combination of z-scores will still control the
type I error, although its optimal properties may not be guaranteed for non-normal phenotypes.
Our framework is closely related to the noisy measurement model (NMM) in that both the
power calculation and the connection to weighted combination of statistics are based on NMM. In
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Methods, we showed that we can assume a more complex polygenic model, and NMM is equivalent
to polygenic model where we assume that the genetic correlation is the same as environmental
correlation. For situations that this is not the case, we also developed weighted combination of
statistics approach that is optimized for polygenic model. If we have an accurate estimate of genetic
and environmental correlations, using this approach may show better performance. However, esti-
mating genetic correlations using SNP data often requires thousands of individuals. By contrast,
the phenotypic correlations can be accurately measured relatively easily from a much smaller set of
individuals. Therefore, we expect that our standard solution based on phenotypic correlation and
NMM will be a practical solution for situations that the size of complete dataset is small. Moreover,
our analysis based on real data shows that NMM is a reasonable model for most of loci that we
evaluated.
An implicit assumption of our approach is that we expect that we can borrow information of
target phenotype from the proxy phenotypes. That is, we assume that there will be pleiotropy
between phenotypes that are reflected in correlations. If this is not the case, such as the TG-
associated locus (rs1260326) that were not at all associated to other phenotypes, the power to
detect such a locus using other phenotypes is considerably limited. Note that this is not the
limitation of only our method, but can be a limitation of any possible approaches that depend on
proxy phenotypes. Nevertheless, our NFBC analysis shows that such situation is relative rare (one
out of seven loci) compared to the situations that our method was effective.
It is worth mentioning that phenotype imputation has some similarities to phenotype prediction.
In phenotype prediction, one typically predicts phenotypes based on available genetic information.
One of the widely used methods for phenotype prediction is BLUP (Best Linear Unbiased Pre-
diction) [19]. Phenotype prediction is an active research area, and various approaches have been
proposed to solve this problem efficiently [32, 34]. The main difference between phenotype predic-
tion and phenotype imputation lies in the main goal of the approaches. The main goal of phenotype
prediction is to have a method that predicts the phenotypic values as close as possible to the true
value using the genetic data and possibly using other phenotypes. However, in phenotype imputa-
tion, the goal is to impute the phenotypic values using other phenotypes such that we can recover
the associated signals had we have collected the imputed phenotype. Therefore, we can not use the
genetic data for phenotype imputation. If we utilize the genetic data in our imputation, we would
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not be able to perform genetic association because the genetic data would be used twice (once in
imputation and once again in the GWAS).
Phenotype imputation is in several ways analogous to genotype imputation [8, 22, 23, 26, 30].
In genotype imputation, we want to impute the missing genotypes. As in phenotype imputation,
if we use one tagged variant in the genotype imputation to impute the missing variant, we lack
sufficient power when we perform GWAS on the imputed genotype. However, if we use a panel
of reference individuals and multiple variants, we can achieve higher power. This is similar to our
phenotype imputation where utilization of multiple phenotypes will achieve higher power than only
using one phenotype. These similarities are the reasons we use the name “phenotype imputation”
for this problem.
Our method controls type I errors even in the scenario that there are systematic differences
between the reference (first dataset) and target (second dataset) datasets. In the case of systematic
differences, power will be affected, but our method will not report false positives.
We acknowledge the fact that more sophisticated machine learning can be utilized, including
techniques such as support vector machines (SVM) [9], LASSO [47], Elastic-net [55], and supervised
PCA [4] to solve the phenotype imputation problem and improve the imputation power. Moreover,
these methods do not make any assumption on the distribution of collected phenotypes. However,
these methods are designed for general missing data problems and do not utilize the genetic data.
Recently, a multiple imputation method [10] is proposed that incorporate the genetic similarity
(kinship) between individuals to perform phenotype imputation. This method performs better
than generalized machine learning methods described above. However, all of these methods require
access to individuals’ raw data which in most cases is not possible. This is one the main advantages
of our method that we can perform imputation using available summary statistics. In addition,
we provide an analytical power calculation for our method, while performing analytical power
computation is not easy for other methods.
In our approach, due to our parametric assumptions, we know the exact distribution of the
imputed phenotype and can directly use the mean value of this distribution as the imputed value.
Furthermore, we utilize the variance of the missing phenotype in our analysis of the statistical
power. If we are using a more sophisticated machine learning method for the imputation, such as
the methods mentioned above, we can use multiple imputation techniques [39, 40] to obtain the
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confidence intervals for the imputation.
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Appendix
Phenotype rimp
TG 0.58
HDL 0.41
LDL 0.34
BMI 0.61
CRP 0.37
GLU 0.33
INS 0.62
SBP 0.63
DBP 0.63
Height 0.10
Table S.1: The rimp computed for the 10 phenotypes using the other nine phenotypes in NFBC dataset.
Phenotype imputation for cases where different subsets of phenotypes are miss-
ing
In the method section, we explained our method, as the target phenotype is the only missing pheno-
type. Unfortunately, when the number of related phenotypes is large there exist many individuals
where one or more phenotypic values are missing. Let c indicate a vector of size `−1 where each el-
ement of the vector is zero or one value. Vector c indicates which phenotypes are missing excluding
the target phenotype, the i-th element of c is one for the cases where the i-th phenotype is missing.
We refer to c as one configuration of missing phenotypes in the second dataset. Given we have
` − 1 phenotypes, we have at most 2`−1 such configurations. Let C indicate the set of all possible
configurations, C = {c1, c2, · · · c2`−1}. Let Y (2)ci indicate a new partition of the second dataset to set
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Phenotype β se(β) Z-score P-value
TG -0.037 0.006 -5.37 8.159e-08
HDL 0.005 0.005 0.984 0.325
LDL -0.012 0.013 -0.977 0.328
BMI -0.035 0.022 -1.594 0.110
CRP 0.001 0.001 1.1737 0.240
GLU 0.003 0.005 0.699 0.484
SBP 0.028 0.189 0.152 0.879
DBP 0.008 0.166 0.050 0.959
Height 0.032 0.095 0.344 0.730
Table S.2: rs1260326 violates the NMM assumption. Association results for rs1260326 on the ten phenotypes
in the NFBC data obtained from EMMAX [24]. As shown, this SNP is significant for TG phenotype.
However, the p-value of this SNP for other phenotypes is extremely high.
of individuals which miss exactly the phenotypes denoted by configuration ci. We can easily extend
our method to impute the target phenotype for these individuals that belong to configuration ci by
removing the phenotypes that are missing for these individuals. Thus, Σ¬` and R¬`` are computed
similarly as mentioned in previous section while we excludes the phenotypes which are missing for
these individuals. Then, we apply Equation (7) and Equation (14) to compute the imputed target
phenotype and the imputed marginal statistics respectively for only these individuals utilizing the
observed phenotypes. It is possible, we can have up to 2`−1 different configurations, thus, we can
have up to 2`−1 different marginal statistics for each configuration. Let sˆci indicate the imputed
marginal statistics for the configuration ci. Then, we compute the total marginal statistics by
applying the fixed-effect meta-analysis as shown in previous section. Thus, we have:
sˆ` =
w1sˆc1 + w2sˆc2 + · · ·+ w2`−1 sˆc2`−1√
w21 + w
2
2 · · ·w22`−1
(27)
where wi is the optimal weight for the marginal statistics for the configuration ci which is pro-
portional to correlation between the imputed target phenotypic values and the true uncollected
phenotypic values for all the individuals in configuration ci.
37
ll
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
ll
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
ll
l
ll
l
l
l
l
l
l
l
ll
l
l
l
l l
l
l
l l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
ll
l
−4 −2 0 2 4
−
4
−
2
0
2
4
Normal Q−Q Plot
Theoretical Quantiles
Sa
m
pl
e 
Qu
an
tile
s
Figure S.1: Q-Qplot of imputed TG phenotype from NFBC dataset. The x-axis is the theoretical distribution
which is standard normal distribution and y-axis is the computed z-score.
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Figure S.2: Q-Qplot of the transformed phenotypes from the NFBC dataset. The x-axis is the theoretical
distribution which is standard normal distribution and y-axis is the transformed phenotypes from the NFBC
dataset. We used the inverse normal transformation on all the 10 phenotypes. We merge all the 10 phenotypes
to one large phenotype and plot the Q-Qplot. This indicates that transformed phenotypes as a set follows
a multivariate normal.
38
D
en
si
ty
−4 −2 0 2 4
0.
0
0.
1
0.
2
0.
3
0.
4
Figure S.3: Difference between the imputed marginal statistics and analytical marginal statistics for BMI
phenotype. Imputed marginal statistics is obtained from the association between the genotype and the
imputed phenotype and analytical marginal statistics is equal to the marginal statistics computed on the
true target phenotype scaled by rimp. The blue curve is the normal distribution with mean zero and variance
1-r2imp. This histogram indicates this difference follows a normal distribution (mean zero and variance 1-
r2imp). Thus, for most null variants the NMM assumption holds.
#individuals Number of phenotypes
3-phen 4-phen 5-phen 6-phen
1000 0.100 ± 0.079 0.087 ± 0.071 0.086 ± 0.068 0.081 ± 0.064
5000 0.043 ± 0.033 0.040 ± 0.031 0.037 ± 0.028 0.034 ± 0.026
10000 0.032 ± 0.024 0.028 ± 0.022 0.023 ± 0.017 0.022 ± 0.015
Table S.3: The residual difference between the computed association statistics for the imputed phenotype
and the analytical association statistics under the case the NMM assumption holds.
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Figure S.4: Difference between the imputed marginal statistics and analytical marginal statistics for SBP
phenotype. Imputed marginal statistics is obtained from the association between the genotype and the
imputed phenotype and analytical marginal statistics is equal to the marginal statistics computed on the
true target phenotype scaled by rimp. The blue curve is the normal distribution with mean zero and variance
1-r2imp. This histogram indicates this difference follows a normal distribution (mean zero and variance 1-
r2imp). Thus, for most null variants the NMM assumption holds.
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Figure S.5: Difference between analytical and empirical value of rimp is small. The x-axis is the phenotype
which we impute using the remaining nine phenotypes from NFBC dataset. The y-axis is the difference
between empirical and analytical value of rimp. The empirical value is the correlation that is computed
between true and imputed phenotype. The analytical value of rimp is
√
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Figure S.6: The pairwise correlation between each pair of phenotype in the HMDP dataset.
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